×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| Concord Drugs Limited | 118.51 | 0.54 | 118.41 | 0.05 | 34.6 | |
| CENTENIAL SURGICAL SUTURE LTD. | 122.04 | -8.48 | 121.99 | -2.30 | 33.6 | |
| TRANSGENE BIOTEK LTD. | 1.21 | -0.88 | 0.77 | -0.01 | 31.8 |
Concord Drugs Limited, with Security Code 538965, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 12.5 | 13.7 | 13.5 | 11.5 | 8.7 | 7.3 | 12.6 | 14.4 | 6.3 | 11.8 |
| Expenses | 11.6 | 12.5 | 12.1 | 10.8 | 7.4 | 5.9 | 12.1 | 14.3 | 5.6 | 11.0 |
| Operating Profit | 1.0 | 1.2 | 1.4 | 0.7 | 1.4 | 1.5 | 0.6 | 0.2 | 0.7 | 0.8 |
| OPM % | 7.78% | 8.65% | 10.67% | 6.42% | 15.91% | 20.7% | 4.44% | 1.29% | 11.51% | 6.7% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 |
| Depreciation | 0.4 | 0.5 | 0.4 | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 |
| Profit before tax | 0.3 | 0.2 | 0.6 | 0.0 | 0.6 | 0.8 | -0.3 | -0.6 | 0.0 | 0.1 |
| Tax % | 26.1% | 24.3% | 26.3% | 305.9% | 22.7% | 30.9% | -6.3% | -38.9% | 55.6% | 27% |
| Net Profit | 0.2 | 0.2 | 0.5 | 0.1 | 0.5 | 0.5 | -0.2 | -0.4 | 0.0 | 0.1 |
| EPS in Rs | 0.21 | 0.21 | 0.52 | 0.07 | 0.52 | 0.56 | -0.24 | -0.35 | 0.01 | 0.05 |
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.3 | 9.0 | 7.5 | 12.8 | 15.6 | 11.7 | 12.4 | 10.8 |
| Expenses | 11.3 | 7.5 | 5.9 | 12.2 | 15.3 | 10.9 | 11.5 | 9.4 |
| Operating Profit | 1.0 | 1.5 | 1.6 | 0.6 | 0.4 | 0.8 | 0.9 | 1.4 |
| OPM % | 7.8% | 16.3% | 21.4% | 4.9% | 2.3% | 7.1% | 7% | 12.9% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
| Depreciation | 0.3 | 0.4 | 0.4 | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 |
| Profit before tax | 0.1 | 0.6 | 0.8 | -0.3 | -0.5 | 0.0 | 0.1 | 0.5 |
| Tax % | 15.6% | 22.8% | 29.6% | -6.2% | -38.2% | 34.1% | 33.3% | 56.9% |
| Net Profit | 0.2 | 0.5 | 0.6 | -0.2 | -0.3 | 0.0 | 0.0 | 0.2 |
| EPS in Rs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | -2% |
| 3 Years: | -6% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 0% |
| 3 Years: | 2% |
| TTM: | -108% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | 4% |
| 1 Year: | -19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 21% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -104% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | 4% |
| 1 Year: | -19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|